Back to search
FDAFDA · Food and drugs·Recall number D-0742-2026

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

Published July 29, 2026 · Recall initiated: June 26, 2026

Summary

FDA records drug Class II recall D-0742-2026, published July 29, 2026 and initiated June 26, 2026. Recalling firm: Bionpharma Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot# 704C003, Exp. 12/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email if DIVALPROEX SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DIVALPROEX SODIUM
Manufacturer
Bionpharma Inc.
Distributor
US Nationwide.
Lot
Lot# 704C003, Exp. 12/31/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. recalled?

Yes. FDA published recall D-0742-2026 on July 29, 2026. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DIVALPROEX SODIUM.